KRASG12C IN-18
目录号 : KM33213 CAS No. : 2966924-24-1
KRASG12C IN-18 是一种口服活性的 KRASG12C 共价抑制剂,可在 GDP 与 GMPPNP 结合状态下实现对 KRASG12C 的完全共价结合,并对 KRASG12C 及其耐药相关突变体(包括 KRASG12C/R68S)表现出显著的抗增殖活性,IC50 为低纳摩尔水平。KRASG12C IN-18 在 KRASG12C 驱动的实体瘤及 KRASG12C/R68S 异种移植模型中表现出显著的体内活性,可用于直肠腺癌研究。
规格 价格 是否有货 数量
50mg 询价 In-stock
100mg 询价 In-stock
250mg 询价 In-stock

Other Forms of Rapamycin:

KKL Med 的所有产品和服务仅用于科学研究,不能被用于人体,兽医,我们也不向个人提供产品和服务。
生物活性
KRASG12C IN-18 is an orally active covalent KRASG12C inhibitor that achieves complete covalent engagement of KRASG12C in both GDP- and GMPPNP-bound states and displays strong antiproliferative activity against KRASG12C and resistance-associated variants, including KRASG12C/R68S, with low-nanomolar IC50 values.KRASG12C IN-18 exhibits marked in vivo efficacy in KRASG12C-driven solid tumor and KRASG12C/R68S xenograft models and can be used for colorectal cancer research.
分子式
C37H32F4N6O2
分子量
668.68
CAS号
2966924-24-1
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years
  4°C 2 years
In solvent -80°C 6 months
  -20°C 1 month
The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2